Call Options

8 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$31.71 - $43.0 $88,788 - $120,400
-2,800 Reduced 20.29%
11,000 $407,000
Q1 2022

May 16, 2022

SELL
$29.88 - $37.04 $35,856 - $44,448
-1,200 Reduced 8.0%
13,800 $511,000
Q4 2021

Feb 15, 2022

BUY
$25.61 - $35.1 $130,611 - $179,010
5,100 Added 51.52%
15,000 $456,000
Q3 2021

Nov 15, 2021

SELL
$33.54 - $40.55 $707,694 - $855,604
-21,100 Reduced 68.06%
9,900 $332,000
Q2 2021

Aug 16, 2021

SELL
$34.54 - $47.25 $977,482 - $1.34 Million
-28,300 Reduced 47.72%
31,000 $1.24 Million
Q1 2021

May 17, 2021

SELL
$42.51 - $63.78 $454,857 - $682,446
-10,700 Reduced 15.29%
59,300 $2.67 Million
Q4 2020

Feb 16, 2021

BUY
$45.3 - $60.27 $1.81 Million - $2.41 Million
40,000 Added 133.33%
70,000 $3.96 Million
Q3 2020

Nov 13, 2020

BUY
$47.45 - $62.95 $1.42 Million - $1.89 Million
30,000 New
30,000 $1.42 Million

Others Institutions Holding IONS

About IONIS PHARMACEUTICALS INC


  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $5.64B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track This Portfolio

Track Sg3 Management, LLC Portfolio

Follow Sg3 Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg3 Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg3 Management, LLC with notifications on news.